Search
for
Sort by
Research 30 of 1000+
- Shedding light on the FDA’s 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia
- Low‐level laser (light) therapy (LLLT) for treatment of hair loss
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Alopecia areata: current concepts
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Safety and efficacy of transdermal testosterone for treatment of hypoactive sexual desire disorder
- Relating neurosteroid modulation of inhibitory neurotransmission to behaviour
- A Porcine Model for the Development and Testing of Preoperative Skin Preparations
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Novel inhibitors of 5α-reductase
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Efficacy and safety of platelet rich plasma therapy in male androgenetic alopecia
- Lasers in Hair Growth and Hair Transplantation
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Lipid nanocarriers as innovative strategies for hair regrowth
- Androgenetic alopecia; drug safety and therapeutic strategies
- Minoxidil: a comprehensive review
- Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Inconsistent platelet-rich plasma product from devices cleared by the US FDA: A retrospective review of clinic data
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Efficacy of Platelet-Rich Plasma versus 5% Topical Monixidil for the Treatment of Androgenetic Alopecia
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review